Beijing Chao Yang Hospital
Clinical trials sponsored by Beijing Chao Yang Hospital, explained in plain language.
-
Can a probiotic help tame New-Onset diabetes?
Disease control Not yet recruitingThis study looks at whether a probiotic called Lactobacillus paracasei LC19 can improve blood sugar control in people recently diagnosed with type 2 diabetes. About 70 adults who have not taken diabetes medication will take the probiotic daily for 12 weeks. Researchers will measu…
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
Can pressurized oxygen boost stroke recovery? new trial aims to find out
Disease control Not yet recruitingThis study tests whether hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) can help people recover better after a stroke. About 424 adults aged 35-75 who had a stroke and received a procedure to reopen a blocked artery will receive either standard care or standar…
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Could early aspirin after stroke save more brains?
Disease control Not yet recruitingThis study tests whether giving a low-dose aspirin just 2 hours after clot-busting treatment for stroke is safer and more effective than waiting the standard 24 hours. About 210 adults aged 18-65 with acute ischemic stroke will be randomly assigned to early or standard aspirin ti…
Phase: PHASE4 • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New ventilation method aims to shield heart in severe pneumonia
Disease control Not yet recruitingThis study tests a new way to use a breathing machine to protect the right side of the heart in patients with severe pneumonia and lung injury. About 180 adults will be assigned to either the new method or the standard one. The goal is to see if the new approach reduces heart com…
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Gut check: semaglutide study probes hidden bacteria link
Knowledge-focused Not yet recruitingThis study looks at how the weight-loss drug semaglutide changes the gut bacteria in 40 adults with obesity. Participants will take semaglutide for 12 weeks, and researchers will analyze their stool samples to see how the bacteria in their intestines shift. The goal is to better …
Sponsor: Beijing Chao Yang Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 06:51 UTC